In 2015, only 49% of notified multi-drug resistant tuberculosis (MDR-TB) patients in China were estimated to have initiated treatment, compared with 90% of those worldwide. A case-control study was conducted to identify the reasons for non-enrollment in treatment among MDR-TB patients in Hunan province, China. All detected MDR-TB patients registered in designated MDR-TB hospitals in Hunan province from 2011 to 2014 were included and followed until June 2015 to determine their treatment status. Approximately 33.8% (482/1425) of patients were not enrolled in standardized treatment. Factors associated with lower enrollment rate were: age greater than 60 years, living in rural area, unemployed or occupation unreported. Of those who were not enr...
Objectives To examine changes in the screening, diagnosis, treatment and management of drug-resistan...
China faces a critical epidemic of high incidence of multi-drug resistant Tuberculosis (MDR-TB) in a...
Background: Screening on multidrug-resistant tuberculosis (MDR-TB) has been limited to the serious T...
Background The rapid spread of multidrug-resistant tuberculosis (MDR-TB) has attracted global concer...
<div><p>Background</p><p>We conducted a first baseline survey in Jilin Province of China to determin...
<div><h3>Background</h3><p>The multidrug-resistant (MDR) and extensively drug-resistant (XDR) tuberc...
Multi-drug resistant tuberculosis (MDR-TB) represents a threat to health and development in countrie...
Abstract Background The directly observed therapy-short course (DOTS) strategy was introduced in Sha...
Multi drug resistant tuberculosis (MDR-TB) is an important source of infection, and it has been a bi...
Multi-drug resistant tuberculosis (MDR-TB) represents a threat to health and development in countrie...
Objectives To examine changes in the screening, diagnosis, treatment and management of drug-resistan...
As China is one of high MDR-TB burden countries, it is important to determine the drug resistant pat...
BACKGROUND: The worldwide emergence of multidrug-resistant tuberculosis (MDR-TB) and extensively dru...
China is one of the top 30 countries with high multidrug-resistant tuberculosis (MDR-TB) and rifampi...
BACKGROUND: Information on treatment outcomes among hospitalized patients with multidrug-resistant t...
Objectives To examine changes in the screening, diagnosis, treatment and management of drug-resistan...
China faces a critical epidemic of high incidence of multi-drug resistant Tuberculosis (MDR-TB) in a...
Background: Screening on multidrug-resistant tuberculosis (MDR-TB) has been limited to the serious T...
Background The rapid spread of multidrug-resistant tuberculosis (MDR-TB) has attracted global concer...
<div><p>Background</p><p>We conducted a first baseline survey in Jilin Province of China to determin...
<div><h3>Background</h3><p>The multidrug-resistant (MDR) and extensively drug-resistant (XDR) tuberc...
Multi-drug resistant tuberculosis (MDR-TB) represents a threat to health and development in countrie...
Abstract Background The directly observed therapy-short course (DOTS) strategy was introduced in Sha...
Multi drug resistant tuberculosis (MDR-TB) is an important source of infection, and it has been a bi...
Multi-drug resistant tuberculosis (MDR-TB) represents a threat to health and development in countrie...
Objectives To examine changes in the screening, diagnosis, treatment and management of drug-resistan...
As China is one of high MDR-TB burden countries, it is important to determine the drug resistant pat...
BACKGROUND: The worldwide emergence of multidrug-resistant tuberculosis (MDR-TB) and extensively dru...
China is one of the top 30 countries with high multidrug-resistant tuberculosis (MDR-TB) and rifampi...
BACKGROUND: Information on treatment outcomes among hospitalized patients with multidrug-resistant t...
Objectives To examine changes in the screening, diagnosis, treatment and management of drug-resistan...
China faces a critical epidemic of high incidence of multi-drug resistant Tuberculosis (MDR-TB) in a...
Background: Screening on multidrug-resistant tuberculosis (MDR-TB) has been limited to the serious T...